Volume 124, Issue 3, Pages (March 2003)

Slides:



Advertisements
Similar presentations
CD4+CD45RBHi Interleukin-4 Defective T Cells Elicit Antral Gastritis and Duodenitis Taeko Dohi, Kohtaro Fujihashi, Toshiya Koga, Yuri Etani, Naoto Yoshino,
Advertisements

Targeting Improves MSC Treatment of Inflammatory Bowel Disease
FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice
Pancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Volume 119, Issue 1, Pages (July 2000)
Volume 25, Issue 2, Pages (August 2006)
HongMei Li, MeiFang Dai, Yuan Zhuang  Immunity 
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 122, Issue 5, Pages (May 2002)
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 5, Pages (November 2012)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 132, Issue 4, Pages (April 2007)
Volume 119, Issue 1, Pages (July 2000)
Volume 25, Issue 3, Pages (September 2006)
Volume 130, Issue 2, Pages (February 2006)
Volume 133, Issue 1, Pages (July 2007)
Therapeutic potential of follistatin for colonic inflammation in mice
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy by Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew Flies, Sarah.
Volume 120, Issue 5, Pages (April 2001)
Induction of Autoimmunity in a Bleomycin-Induced Murine Model of Experimental Systemic Sclerosis: An Important Role for CD4+ T Cells  Hideaki Ishikawa,
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1/CD301a by Kayoko Sato, Yasuyuki Imai,
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 7, Pages (June 2007)
Volume 128, Issue 5, Pages (May 2005)
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Volume 130, Issue 2, Pages (February 2006)
HongMei Li, MeiFang Dai, Yuan Zhuang  Immunity 
Volume 134, Issue 4, Pages e2 (April 2008)
IFN-γ activates the fibrinolytic system.
Volume 16, Issue 4, Pages (April 2002)
Volume 123, Issue 6, Pages (December 2005)
Volume 29, Issue 2, Pages (August 2008)
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4+ T Cells  Cynthia A Chambers, Timothy J Sullivan,
Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity  Zhang-Xu Liu, Sugantha Govindarajan,
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 7, Issue 2, Pages (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 120, Issue 4, Pages (March 2001)
FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 29, Issue 2, Pages (August 2008)
Volume 128, Issue 4, Pages (April 2005)
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
Sarita Sehra, PhD, Weiguo Yao, PhD, Evelyn T. Nguyen, MS, Nicole L
Volume 121, Issue 6, Pages (December 2001)
Volume 119, Issue 3, Pages (September 2000)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Volume 127, Issue 5, Pages (November 2004)
Volume 119, Issue 1, Pages (July 2000)
Volume 123, Issue 6, Pages (December 2002)
Volume 121, Issue 4, Pages (October 2001)
Volume 117, Issue 5, Pages (November 1999)
Volume 131, Issue 2, Pages (August 2006)
Volume 14, Issue 3, Pages (March 2001)
Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist  Scott E. Wenderfer, Stanislaw.
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
Volume 127, Issue 3, Pages (September 2004)
No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand–deficient.
Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease  Wonyoung Kim, Juyang.
Volume 35, Issue 4, Pages (October 2011)
IFN-γ activates the fibrinolytic system.
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 124, Issue 3, Pages 672-682 (March 2003) T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell–deficient mice  Taeko Dohi, Kohtaro Fujihashi, Toshiya Koga, Yuko Shirai, Yuki I. Kawamura, Chieko Ejima, Rie Kato, Kiyoshi Saitoh, Jerry R. McGhee  Gastroenterology  Volume 124, Issue 3, Pages 672-682 (March 2003) DOI: 10.1053/gast.2003.50092 Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 1 Comparison of wasting disease after adoptive transfer of RBHi T cells. (A) Example of the reanalysis of sorted RBHi T cells used for adoptive transfer. After sorting, PE-labeled CD45RBHi T cells were stained with FITC-labeled anti-TCRγδ Ab, anti-NK1.1 Ab, and Gr-1 Ab. PE-negative cells include photo-bleached cells. The RBHi T cell subset was >99% pure. Similar purity was obtained in RBLo T cells. (B) Weight loss after adoptive transfer of Wt (open circle) and IFN-γ−/− (solid circle) RBHi T cells to TCR−/− recipients. Weight changes of age-matched TCR−/− mice are also shown (diamonds). Data are given as the mean and standard error of the mean of 5 mice. Asterisks show statistically significant differences from recipients of Wt RBHi T cells. (C) IFN-γ−/− RBLo T cell transfer did not induce wasting disease, and treatment with anti–IFN-γ mAb after adoptive transfer did not change wasting disease of TCR−/− recipients of IFN-γ−/− RBHi T cells. SCID recipients of IFN-γ−/− RBHi T cells did not show severe weight loss. Bars indicate mean value. Data are given as the mean and standard error of the mean. Asterisks indicate statistically significant difference. Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 2 H&E-stained sections of the colonic and ileal lesions of TCR−/− and SCID recipient mice. Colitis was severe in the TCR−/− (C) and SCID (G) recipients of Wt RBHi T cells but mild in TCR−/− (E) and SCID (I) recipients of IFN-γ−/− RBHi T cells. No significant change was seen in the ileum from the TCR−/− recipients of Wt RBHi T cells except for mild cell infiltration (D), whereas villus atrophy was evident in the ileum in the TCR−/− recipients of IFN-γ−/− RBHi T cells (F). No evident villus atrophy was seen in the ileum from SCID recipients of Wt (H) or IFN-γ−/− (J) RBHi T cells. Colon and ileum from TCR−/− mice without T cell transfer are shown in (A) and (B), respectively. (Original magnification 10× in pictures of the colon and 20× in those of the ileum.) Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 3 Comparison of parameters for tissue pathology in the ileum of TCR−/− and SCID recipients of RBHi T cells. (A) Height of villi and (B) length of crypts were measured in H&E-stained sections. (C) Length of the proliferating zone was measured after staining with anti-Ki67 Ab as shown in Figure 4. (D) The area occupied by goblet cells was detected by PAS reactivity, like the typical cells shown in Figure 4. The bars represent the mean and standard error of the mean. An asterisk indicates a statistically significant difference from the data without asterisks. Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 4 Histochemical analysis of the ileum of TCR−/− recipients of Wt or IFN-γ−/− RBHi T cells. Paraffin-embedded sections were stained for ALP (in red), for Ki67 antigen (in black), and for mucin by PAS (in purple-red). (Original magnification for ALP and PAS staining, 40×; for Ki67 staining, 10×.) Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 5 Ileal lesions in SCID recipients of B220+ cells and IFN-γ−/− RBHi T cells. SCID recipient mice received an intravenous injection of 2×106 B220+ cells prepared from the mesenteric lymph nodes of Wt mice. Three days later, an aliquot of 1×106 IFN-γ−/− RBHi T cells were transferred to a group of recipients. (A) The height of villi and the PAS-positive areas in the ileum were determined as was done in Figure 3. Blank bars are SCID recipients of only B220+ cells; solid bars are SCID recipients of B220+ cells and IFN-γ−/− RBHi T cells. The bars represent the mean and standard error of the mean of 5 mice. An asterisk indicates a statistically significant difference from the data without asterisks. A separate set of experiments using B cells prepared independently reproduced the same results. (B) Ileal frozen sections were prepared from SCID recipients of B220+ cells (left) or B220+ cells and IFN-γ−/− RBHi T cells (right). The sections were stained with hematoxylin and eosin (top), PAS (middle), or biotin-labeled goat anti-mouse IgA antibody followed by aminocoumarin-labeled streptavidin (bottom). (Original magnification for H&E and PAS staining, 20×; for IgA staining, 10×.) Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 6 Treatment of TCR−/− recipients of IFN-γ−/− RBHi T cells with anti–IL-4 mAb. A dose of 1 mg of anti–IL-4 mAb or control rat IgG was injected weekly after adoptive transfer. Each group included 4 mice. (A) Weight loss was prevented by the treatment. Bars show the mean values. (B) Length of villi and (C) length of proliferating zone were increased in the recipients treated with anti–IL-4 mAb. (D) Goblet-cell area decreased in the recipients treated with anti–IL-4 mAb. Data are shown as the mean and the standard error of the mean. An asterisk indicates a statistically significant difference. Gastroenterology 2003 124, 672-682DOI: (10.1053/gast.2003.50092) Copyright © 2003 American Gastroenterological Association Terms and Conditions